Synthesis and in vitro antiproliferative activity of novel (4-chloro- and 4-acyloxy-2-butynyl)thioquinolines
摘要:
The series of new acetylenic thioquinolines containing propargyl, 4-chloro-2-butynyl, and 4-acyloxy-2-butynyl groups have been prepared and tested for antiproliferative activity in vitro against human [SW707 (colorectal adenocarcinoma), CCRF/CEM (leukemia), T47D (breast cancer)] and murine [P388 (leukemia), B16 (melanoma)] cancer lines. Most of the obtained compounds exhibited antiproliferative activity, especially compounds 8, 12, and 21 showed the ID50 values ranging from 0.4 to 3.8 mu g/ml comparable to that of cisplatin used as reference compounds.
Synthesis and antiproliferative activity in vitro of novel (2-butynyl)thioquinolines
摘要:
The series of new acetylenic thioquinolines containing propargyl, 2-butynyl, 4-bromo-2-butynyl, and 4-hydroxy- 2-butynyl groups has been prepared and tested for antiproliferative activity in vitro against human [SW707 ( colorectal adenocarcinoma), CCRF/CEM ( leukemia)] and murine [P388 ( leukemia), B16 ( melanoma)] cancer lines. All the compounds obtained exhibited antiproliferative activity. The most active compounds 7, 16, 17, and 19 have the ID(50) values ranging from 0.2 to 4.6 mu g/ml comparable to that of cisplatin used as referencecompounds. (C) 2008 Elsevier Ltd. All rights reserved.
The series of new acetylenic thioquinolines containing propargyl, 4-chloro-2-butynyl, and 4-acyloxy-2-butynyl groups have been prepared and tested for antiproliferative activity in vitro against human [SW707 (colorectal adenocarcinoma), CCRF/CEM (leukemia), T47D (breast cancer)] and murine [P388 (leukemia), B16 (melanoma)] cancer lines. Most of the obtained compounds exhibited antiproliferative activity, especially compounds 8, 12, and 21 showed the ID50 values ranging from 0.4 to 3.8 mu g/ml comparable to that of cisplatin used as reference compounds.
Synthesis and antiproliferative activity in vitro of novel (2-butynyl)thioquinolines
The series of new acetylenic thioquinolines containing propargyl, 2-butynyl, 4-bromo-2-butynyl, and 4-hydroxy- 2-butynyl groups has been prepared and tested for antiproliferative activity in vitro against human [SW707 ( colorectal adenocarcinoma), CCRF/CEM ( leukemia)] and murine [P388 ( leukemia), B16 ( melanoma)] cancer lines. All the compounds obtained exhibited antiproliferative activity. The most active compounds 7, 16, 17, and 19 have the ID(50) values ranging from 0.2 to 4.6 mu g/ml comparable to that of cisplatin used as referencecompounds. (C) 2008 Elsevier Ltd. All rights reserved.